(Q33317042)

25 July 2017

title

Salvage radiotherapy for patients with PSA relapse after radical prostatectomy: a single institution experience (English)

1 reference

adaptive radiation therapy

25 July 2017

main subject

0 references

3

Vincent Ravery

1 reference

25 July 2017

6

Christophe Hennequin

1 reference

25 July 2017

2

Pierre Mongiat-Artus

1 reference

25 July 2017

François Desgrandchamps

series ordinal

5

object named as

François Desgrandchamps

1 reference

25 July 2017

Laurent Quero

1

1 reference

25 July 2017

Claude Maylin

series ordinal

4

1 reference

25 July 2017

language of work or name

English

0 references

publication date

29 January 2008

1 reference

25 July 2017

1 reference

25 July 2017

volume

8

1 reference

25 July 2017

page(s)

26

1 reference

Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial

25 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2257956

Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2257956

Salvage radiotherapy for biochemical failure of radical prostatectomy: a single-institution experience

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2257956

Prediction of response to salvage radiation therapy in patients with prostate cancer recurrence after radical prostatectomy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2257956

PSA based review of adjuvant and salvage radiation therapy vs. observation in postoperative prostate cancer patients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2257956

Consensus statements on radiation therapy of prostate cancer: guidelines for prostate re-biopsy after radiation and for radiation therapy with rising prostate-specific antigen levels after radical prostatectomy. American Society for Therapeutic Radi

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2257956

Natural history of progression after PSA elevation following radical prostatectomy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2257956

Impact of Radical Prostatectomy in the Management of Clinically Localized Disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2257956

Salvage radiotherapy for recurrent prostate cancer: the earlier the better

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-26

Observations on the doubling time of prostate cancer. The use of serial prostate-specific antigen in patients with untreated disease as a measure of increasing cancer volume

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-26

Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-26

Postoperative radiotherapy for carcinoma of the prostate: impact on both local control and distant disease-free survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-26

Biochemical disease-free survival following adjuvant and salvage irradiation after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-26

Salvage radiotherapy for rising or persistent PSA after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-26

Cancer incidence and mortality in Europe, 2004

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-26

Is anastomotic biopsy necessary before radiotherapy after radical prostatectomy?

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2257956

Management of biochemical failure following radical prostatectomy: salvage radiotherapy - a case series

31 October 2018

1 reference

12 December 2020

Radiotherapy for a rising prostate-specific antigen after radical prostatectomy: the first 10 years

1 reference

12 December 2020

Adjuvant and salvage radiation therapy after radical prostatectomy for adenocarcinoma of the prostate

1 reference

12 December 2020

Radiotherapy for PSA recurrence after radical prostatectomy

1 reference

12 December 2020

Salvage radiotherapy after radical prostatectomy for prostate adenocarcinoma: analysis of efficacy and prognostic factors

1 reference

12 December 2020

Predictive factors of radiation therapy for patients with prostate specific antigen recurrence after radical prostatectomy

1 reference

12 December 2020

Adjuvant and salvage radiotherapy after radical prostatectomy for prostate cancer

1 reference

12 December 2020

Salvage radiotherapy for biochemical recurrence after radical prostatectomy: a study of 62 patients

1 reference

12 December 2020

Salvage radiotherapy for men with isolated rising PSA or locally palpable recurrence after radical prostatectomy: do outcomes differ?

1 reference

12 December 2020

Can Radical Prostatectomy Alter the Progression of Poorly Differentiated Prostate Cancer?

1 reference

12 December 2020

Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)

1 reference

12 December 2020

Prostate-specific antigen after anatomic radical retropubic prostatectomy. Patterns of recurrence and cancer control

1 reference

12 December 2020

Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy

1 reference

12 December 2020

Tolerance and early outcome results of postprostatectomy three-dimensional conformal radiotherapy

1 reference

12 December 2020

Long-term results of radiation therapy for prostate cancer recurrence following radical prostatectomy

1 reference

12 December 2020

Prostate-specific antigen velocity accurately predicts response to salvage radiotherapy in men with biochemical relapse after radical prostatectomy

1 reference

12 December 2020

Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911)

1 reference

12 December 2020

Salvage radiotherapy for isolated prostate specific antigen increase after radical prostatectomy: evaluation of prognostic factors and creation of a prognostic scoring system

1 reference

12 December 2020

Long-term results and predictive factors of three-dimensional conformal salvage radiotherapy for biochemical relapse after prostatectomy

1 reference

12 December 2020

Radiotherapy for isolated serum prostate specific antigen elevation after prostatectomy for prostate cancer

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2407-8-26

1 reference

Dimensions Publication ID

25 July 2017

0 references

1 reference

25 July 2017

1 reference